A molecule designed to correct a rare metabolic error in human biochemistry has revealed, through quantum mechanical scrutiny, a hidden kinship with the survival machinery of some of humanity's oldest parasitic adversaries. Nitisinone, long approved to treat tyrosinemia, blocks an enzyme that blood-feeding parasites — from malaria-carrying mosquitoes to the trypanosomes behind sleeping sickness — depend upon to neutralize their own toxic byproducts. In the logic of drug repurposing, what already exists and is trusted may be redirected toward diseases that have resisted eradication for generati
Quantum analysis reveals nitisinone's potential beyond tyrosinemia treatment
Malaria, sleeping sickness, and bed bug infestations cause significant morbidity and mortality globally, particularly in sub-Saharan Africa and resource-limited settings.